Skip to main content

InfuSystem Holdings, Inc

corporate_fare Company Profile

InfuSystem Holdings, Inc

INFU·NYSE·Industrial Applications And Services·CIK 0001337013

InfuSystem Holdings, Inc is a national healthcare service provider that facilitates outpatient care for Durable Medical Equipment (DME) manufacturers and healthcare providers. Formed in 2005, the Delaware corporation operates through its subsidiary InfuSystem, Inc., also a Delaware corporation. It provides products and services to hospitals, oncology practices, ambulatory surgery centers, and other alternate site healthcare providers. The company is headquartered in Rochester Hills, Michigan, and operates from a total of seven locations in the United States and Canada. InfuSystem runs its business under a two-platform model: Patient Services and Device Solutions. Patient Services, the lead platform, provides last-mile solutions for clinic-to-home healthcare where continuing treatment involves complex DME and related services. It offers turnkey solutions designed to be implemented without service disruptions, allowing healthcare provider customers to focus on practicing medicine. Device Solutions complements Patient Services to enhance growth in existing markets and is strategically oriented around the company's existing relationships with healthcare providers, seeking to incrementally capitalize on opportunities related to other services their practices offer or may plan to offer. Over the last 30 plus years, InfuSystem has developed expertise and a service offering that DME manufacturers and healthcare providers use to reduce costs, improve service, and provide options for patients who want to continue healthcare treatments from home. The company has developed a Patient Services model in oncology and believes it can extend this model into other DME therapies by leveraging the infrastructure of its existing platforms and incrementally adding capabilities to existing systems, such as sales, clinical, logistics, revenue cycle management, and biomedical services.

InfuSystem Holdings, Inc (NYSE:INFU) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 3 items for INFU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 3 most recent items scored 7 or higher, the top rating is 7/10. Recent SEC coverage for INFU spans 10-Q, 8-K.

Recent high-impact activity:

  • InfuSystem 10-Q Details $5.0M ERP Billing Backlog Behind Q3 Cash Drag
  • InfuSystem Posts Delayed Q3 Results: Revenue $37.6M, Adjusted EBITDA $9.4M, Guidance Reaffirmed
  • InfuSystem Postpones Q3 Results to Review $4.2M ERP Cost Accounting

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$143.44M
Net Income
$6.63M
Diluted EPS
$0.31
Op. Cash Flow
$24.41M
Free Cash Flow
$23.85M
Gross Profit
$80.3M
Operating Income
$11.92M
Cash & Equivalents
$3.19M
Total Debt
$19.63M
Debt / Equity
0.34×
Net Margin
4.6%
Shares Outstanding
20.21M sh
Source: 10-K · filed 2026-02-27 · accession 0001628280-26-012804

Short Interest & Short Volume

5.71 days to cover

FINRA reported short interest of 683,086 shares in INFU as of the October 30, 2026 settlement, a 16.0% decrease from the prior period — about 5.7 days to cover at its recent average daily volume. On November 19, 2026, 41.5% of INFU volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)683,086 shares as of October 30, 2026
Change vs prior period▼ 16.0%
Days to cover5.71 at avg daily volume of 119,573
Daily short volume (FINRA facilities)41.5% of 97,162 shares on November 19, 2026
5-day average short volume55.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$14.34 +1.99% today
52-week range · as of 2026-11-09 $7.29 – $14.85
Market cap
$287.28M
Volume
162.7K (1.1× avg)
3-mo avg 150.6K
Live data · 2026-11-20 20:54 UTC · Market open

show_chartPrice Chart

Loading chart...

feed INFU - Latest Insights

INFU
Nov 09, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.68
Real-time Price: $14.34 info
Change: -$0.340 (-2%) info
Market Cap: $287.28M info
INFU
Nov 05, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.15
Real-time Price: $14.34 info
Change: +$1.19 (+9%) info
Market Cap: $287.28M info
INFU
Nov 03, 2026, 8:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.84
Real-time Price: $14.34 info
Change: +$0.500 (+4%) info
Market Cap: $287.28M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets